School of Medicine
Showing 101-199 of 199 Results
-
Eon Joseph Rios, MD, PhD
Clinical Assistant Professor (Affiliated), Dermatology
Staff, DermatologyBioEon Rios, M.D., Ph.D., is a Clinical Assistant Professor (Affiliated) of Dermatology at Stanford University and Attending Physician at Santa Clara Valley Medical Center. His research interests span basic science investigations studying non-coding regulators of epidermal differentiation to investigations of the skin and gut Microbiome in dermatology patients. Clinically he is interested in general and complex medical dermatology.
-
Sonia Rios-Ventura
Family Health Navigator, Medicine - Med/Oncology
BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.
She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing. -
Dan Riskin
Clinical Professor (Affiliated), Surgery - General Surgery
Staff, Surgery - General SurgeryBioDr. Riskin is a Clinical Professor of Surgery at Stanford University and a physician–entrepreneur focused on the application of artificial intelligence in healthcare. His work spans clinical practice, company building, and public policy, with a focus on using clinical data to improve care.
He has founded and led multiple healthcare technology companies applying artificial intelligence to clinical data, with products used by leading health systems, pharmaceutical companies, and insurers and influencing the care of millions of patients. He is the CEO of Verantos, a healthcare AI company focused on improving the reliability of real-world clinical data used in research and care.
Dr. Riskin has contributed to health policy in the United States and internationally, including Congressional testimony related to the 21st Century Cures Act and service on the U.S. Health Information Technology Advisory Committee (HITAC). His work has been featured in The Wall Street Journal and Forbes.
Dr. Riskin received his MD from Boston University, completed residency in surgery at UCLA, and fellowship training in critical care and acute care surgery at Stanford University. He is board-certified in surgery, critical care, palliative care, and clinical informatics. He also holds an MBA from the Massachusetts Institute of Technology and was a Stanford Biodesign Innovation Fellow. -
Jorge Roa
Software Developer Associate, Health Policy
BioJorge Roa is a software developer and data scientist in the Department of Health Policy at Stanford University. Prior to joining Stanford, Jorge completed a research fellowship in the Department of Statistics at the University of Munich. He holds an M.Sc. in Data Science for Public Policy from the Hertie School in Berlin, Germany. Jorge earned a B.A. in Public Policy from the Center for Research and Teaching in Economics (CIDE) in Aguascalientes, Mexico. His work has focused on gastric and colorectal cancer research, helping apply Bayesian methods and decision-analytic models, as well as creating and optimizing algorithms. He also has experience in developing and implementing open-source R packages. Jorge is part of the colorectal cancer group within the Cancer Intervention and Surveillance Modeling Network (CISNET). His research centers on employing data science tools and decision-analytic models to make informed decisions based on data and evidence to improve people’s lives.
-
Jennifer Robinson
Associate Director, Medicine - Med/Stanford Prevention Research Center
Current Role at StanfordAssociate Director, Nutrition Studies Group
-
Alexandre Rodrigues Marra
Contingent Employee, Medicine - Med/Infectious Diseases
Current Role at StanfordResearcher
-
Daniela Rodriguez Martinez
Assistant Manager, Communications, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Manager, Communications @Stanford Byers Center for Biodesign
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Maryam Rostami
Soc Science Rsch Prof 1, Psychiatry and Behavioral Sciences
BioMaryam Rostami is a professional data analyst in the Department of Psychiatry and Behavioral Science at Stanford university, currently working in the area of neuroethics and public health. She got a PhD in cognitive neuroscience and neuroimaging from Tohoku university/Japan that folloed by two years of research in the same area at Stanford university.
-
Charlene Larson Rotandi
Associate Director of Fellowship Education, Pediatrics
Current Role at StanfordAssociate Director of Fellowship Education, Department of Pediatrics
Leads initiatives that support the development, administration, and continuous improvement of the 26 subspecialty programs in the Department of Pediatrics. My work focuses on curriculum development and assessment, program accreditation, faculty and program coordinator development, and enhancing the educational experience for our 130+ trainees. I collaborate closely with program leadership and the Graduate Medical Education office to ensure compliance with accreditation standards while advancing innovative approaches to training, mentorship, and professional development. Through my work, I aim to strengthen our learning community by supporting our educational leaders and fostering a collaborative learning environment that promotes trainee success and well-being. -
Raheleh Roudi
Basic Life Research Scientist, Rad/Pediatric Radiology
BioRaheleh Roudi is a research scientist in the Department of Radiology at Stanford University. Dr. Roudi trained at the Iran University of Medical Sciences, Iran. She worked as an Assistant Professor at the Iran University of Medical Sciences, Iran from 2015 to 2019, before coming to the United States. During this time, Dr. Roudi worked on several projects which have led to successful collaborations with the Karolinska Institute; Charite Universitatsmedizin Berlin; Oslo University Hospital; National University of Singapore; Shanghai University of Traditional Chinese Medicine and University of Brescia, among other internationally recognized institutions.
Dr. Roudi was a visiting scientist in the University of Texas at San Antonio and then appointed as a postdoctoral associate at the University of Minnesota for one year, before joining Stanford University in 2022.
Her research interest focuses on the molecular oncology and immunotherapies of solid tumors and she published more than 40 peer reviewed papers. -
Larissa Roux MD PhD
Adjunct Professor, Medicine - Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Anuradha Roy
Casual - Non-Exempt, Anesthesia - Adult Pain Medicine
BioAnuradha (Anu) Roy is the Project Manager for the NCCIH R01 Grant, Single Session Pain Catastrophizing Treatment Efficacy and Mechanisms Trial in Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford Medical School. Originally from the East Coast, she received her BS in Biomedical Engineering from the University of Virginia and her MSc in Public Health in Developing Countries from London School of Hygiene & Tropical Medicine. After years of working abroad in global public health, her research interest transitioned to the public health impact of chronic health conditions - in particular, chronic pain - and understanding the intersection of mind’s impact on health and well-being. For the past three years, on the R01, she has been running day-to-day operations and management of study recruitment, data collection/pre-processing, and reporting. In the near future, she plans to pursue a PhD in Clinical Psychology. In her spare time, Anu enjoys home/exterior design projects, spending time with her partner and dog, creating community, and finding the best food in the San Francisco Bay Area.
-
Michael Rubin
Adjunct Professor, Medicine
BioMichael P. Rubin, MD, PhD is the Founder and CEO of Northpond Ventures, a multi-billion dollar science driven venture capital firm. Northpond is based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Dr. Rubin has been involved in investing in and developing over 100 startups, in a broad array of disciplines, including medicine, technology, financial services, and global consumer. Dr. Rubin’s experience spans engineering, medicine, surgery, venture capital, and entrepreneurship. Dr. Rubin also holds academic appointments at Harvard and MIT.
-
Perisa Ruhi-Williams, MD
Clinical Assistant Professor (Affiliated), Surgery - General Surgery
Staff, Surgery - General SurgeryBioDr. Perisa Ruhi-Williams is a board-certified General Surgeon practicing at the VA Palo Alto Health Care System. Her clinical practice is centered on utilizing robotic-assisted techniques for metabolic/bariatric surgery and hernia and abdominal wall reconstruction.
She graduated as an Echols Scholar with a Bachelor of Science in Biology from the University of Virginia. She earned her MD from the Virginia Tech Carilion School of Medicine and completed her General Surgery residency at the University of California, Irvine. While in residency, she served as the Chief Resident in Quality and Patient Safety at the VA Long Beach Medical Center. She subsequently completed an advanced fellowship in Minimally Invasive Surgery, Bariatrics, and Foregut Surgery at Stanford Health Care.
Dr. Ruhi-Williams is passionate about advancing surgical education and the wellness of surgical trainees. In addition to her clinical roles, she serves as the Site Director for the Surgery Core Clerkship at VA Palo Alto and Assistant Site Director for the General Surgery Residency Program at VA Palo Alto. -
Erica Marie Rutherford
Data Wrangler, Biomedical Data Science
BioMy career spanning nine years as a data curator has given me a lot of experience and perspective into the workings of scientific data and metadata, and its organization. During my time before graduate school, I attained experience on a variety of fieldwork projects in ecology (2008-2013). During these temporary seasonal assignments, the importance of precision and care in data collection was impressed in me. When I went to graduate school at San Francisco State University (2013-2016), I gained experience in all parts of a molecular biology experiment, from fieldwork to labwork to data analysis. After graduation, I worked at a microbiome focused startup company, Second Genome, as their data curator (2016-2021). While there, I was responsible for curation of metadata for both internal studies for R&D and for clients, and for external studies being brought in for our internal Knowledgebase. While there, I developed an appreciate for ontologies, and developed a custom Second Genome Ontology to handle our metadata. I moved on to the Lattice group, located at Stanford University, where I continued to expand my skills in data curation (2021-present). I have gained experience in handling single cell datasets and their associated metadata, and curating them to meet precise standards. I strive to work collaboratively with data contributors in order to ensure FAIR data standards.
